Australian Journal of General Practice
Formerly Australian Family Physician (AFP)
MBBS, Registrar, Sunshine Hospital, Vic
Molecular targeting agents are revolutionising treatment options, particularly poly adenosine diphosphate–ribose polymerase inhibitors, especially for patients with an underlying BRCA mutation.